Поиск по репозиторию
Статья
2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: Results from the Global Influenza Hospital Surveillance Network
2021
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly established, especially among individuals at increased risk for complications from influenza. We used a test-negative approach to estimate influenza vaccine effectiveness (IVE) against hospitalization with laboratory-confirmed influenza based on data collected from the Global Influenza Hospital Surveillance Network (GIHSN). Methods and Findings: This was a multi-center, prospective, active surveillance, hospital-based epidemiological study during the 2012-2013 influenza season. Data were collected from hospitals participating in the GIHSN, including five in Spain, five in France, and four in the Russian Federation. Influenza was confirmed by reverse transcription-polymerase chain reaction. IVE against hospitalization for laboratory-confirmed influenza was estimated for adult patients targeted for vaccination and who were swabbed within 7 days of symptom onset. The overall adjusted IVE was 33% (95% confidence interval [CI], 11% to 49%). Point estimates of IVE were 23% (95% CI, -26% to 53%) for influenza A(H1N1)pdm09, 30% (95% CI, -37% to 64%) for influenza A(H3N2), and 43% (95% CI, 17% to 60%) for influenza B/Yamagata. IVE estimates were similar in subjects <65 and ≥65 years of age (35% [95% CI, -15% to 63%] vs.31% [95% CI, 4% to 51%]). Heterogeneity in sitespecific IVE estimates was high (I2 = 63.4%) for A(H1N1)pdm09 in patients ≥65 years of age. IVE estimates for influenza B/Yamagata were homogenous (I2 = 0.0%). Conclusions: These results, which were based on data collected from the GIHSN during the 2012-2013 influenza season, showed that influenza vaccines provided low to moderate protection against hospital admission with laboratory-confirmed influenza in adults targeted for influenza vaccination. In this population, IVE estimates against A(H1N1)pdm09 were sensitive to age group and study site. Influenza vaccination was moderately effective in preventing admissions with influenza B/Yamagata for all sites and age groups. © 2014 Puig-Barberà et al.
Цитирование
Похожие публикации
Версии
- 1. Version of Record от 2021-04-27
Метаданные
Название журнала
- PLoS ONE
Том
- 9
Выпуск
- 6
Страницы
- -
Ключевые слова
- influenza vaccine; influenza vaccine; article; drug efficacy; epidemiological monitoring; France; hospital admission; hospitalization; human; influenza; influenza A (H1N1); influenza A (H3N2); influenza B; influenza vaccination; information processing; prospective study; reverse transcription polymerase chain reaction; Russian Federation; seasonal influenza; smear; Spain; adolescent; adult; aged; clinical trial; female; hospitalization; immunology; Influenza, Human; international cooperation; male; middle aged; multicenter study; season; sentinel surveillance; statistics and numerical data; treatment outcome; vaccination; virology; young adult; Adolescent; Adult; Aged; Female; Hospitalization; Humans; Influenza Vaccines; Influenza, Human; Internationality; Male; Middle Aged; Seasons; Sentinel Surveillance; Treatment Outcome; Vaccination; Young Adult
Издатель
- Public Library of Science
Тип документа
- journal article
Тип лицензии Creative Commons
- CC
Правовой статус документа
- Свободная лицензия
Источник
- scopus
